Anfield Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2K Sell
38
-75
-66% -$22.3K ﹤0.01% 419
2025
Q4
$30.9K Buy
113
+75
+197% +$20.4K 0.01% 226
2025
Q3
$10.3K Hold
38
﹤0.01% 329
2025
Q2
$10.5K Hold
38
﹤0.01% 294
2025
Q1
$10.1K Hold
38
﹤0.01% 241
2024
Q4
$8.82K Hold
38
﹤0.01% 250
2024
Q3
$8.38K Hold
38
﹤0.01% 255
2024
Q2
$7.47K Buy
+38
New +$7.85K ﹤0.01% 218

Other funds holding CME

Anfield Capital Management's CME Position: Q1 2026 in Review

Anfield Capital Management reduced its CME Group (CME) stake by 66% in Q1 2026, selling an estimated $22.3K and leaving 38 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Anfield Capital Management first reported a position in CME in Q2 2024 and has held it in 8 quarters since. The position peaked at $30.9K in Q4 2025. 1,799 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Anfield Capital Management held 38 shares of CME Group worth $11.2K as of Q1 2026.
  • Anfield Capital Management sold 75 CME Group shares in Q1 2026, an estimated $22.3K.
  • CME Group made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #419 holding.
  • Anfield Capital Management first reported a position in CME Group in Q2 2024 and has held it in 8 quarters since.
  • Anfield Capital Management's CME Group position peaked at $30.9K in Q4 2025.
  • 1,799 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.